EP Patent

EP0206459A2 — 9-(Phosphonylmethoxyalkyl) adenines, method for their preparation and their use

Assigned to Institute Of Organic Chemistry And Biochemistry Of · Expires 1986-12-30 · 39y expired

What this patent protects

The invention relates to 9-(phosphonylmethoxyalkyl) adenines of the general formula I wherein R 1 is a hydrogen atom, an alkyl group containing one to three carbon atoms, or a hydroxymethyl group, R 2 is a methylene, ethylene, propylene, ethylidene, methoxyethylene, benzyl…

USPTO Abstract

The invention relates to 9-(phosphonylmethoxyalkyl) adenines of the general formula I wherein R 1 is a hydrogen atom, an alkyl group containing one to three carbon atoms, or a hydroxymethyl group, R 2 is a methylene, ethylene, propylene, ethylidene, methoxyethylene, benzyloxyethylene, tetrahydropyran-2- yloxyethy- lene, (1-ethoxyethoxy)ethylene or 1,2-0-isopropylidene-1,2-dihydroxypropylene group the method of their preparation and utilization. Compounds of the general formula I exhibit biological effects (e.g. antiviral) or can be converted into compounds with such effects.

Drugs covered by this patent

Patent Metadata

Patent number
EP0206459A2
Jurisdiction
EP
Classification
—
Expires
1986-12-30
Drug substance claim
No
Drug product claim
No
Assignee
Institute Of Organic Chemistry And Biochemistry Of
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.